The gross proceeds from the offering are expected to be approximately $5 million, prior to deducting placement agent’s fees and other offering expenses payable by the Company. Pasithea intends to use ...

Sudden uncontrollable and inappropriate laughing or crying is a symptom of pseudobulbar affect (PBA), a neurological ...

This article was published by IBN, a multifaceted communications organization engaged in connecting public companies to the ...

In a first-of-a-kind collaboration, Target ALS, a foundation breaking down barriers to amyotrophic lateral sclerosis (ALS) ...

A tailored cocktail of genes can reprogram a subset of progenitors to no longer produce glial cells and instead develop into neurons involved in motor control.

A New Bedford man, Joseph Smith, admitted to stealing over $450,000 in disability benefits from a veteran with ALS and ...

Spinogenix, the company behind the once-a-day pill that restored lost nerve cell connections in people with amyotrophic ...

PolTREG S.A. (Warsaw Stock Exchange: PTG), a clinical-stage biotechnology company developing cellular therapies for a range of autoimmune diseases, today announces it has launched a study with ...

Two specific conditions are exempt from the 24-month waiting period: end-stage kidney disease and amyotrophic lateral sclerosis (ALS). Individuals with these diseases can qualify for Medicare no ...